Analysis | Samples | Factors | Units |
---|---|---|---|
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-01 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-02 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-03 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-04 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-05 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-06 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-07 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-08 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-09 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-10 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-11 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-01 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-02 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-03 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-04 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-05 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-06 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-07 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-08 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-09 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-10 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-11 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-12 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-01 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-02 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-03 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-04 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-05 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-06 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-07 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-08 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-09 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-10 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-11 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-12 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-1-01 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-1-02 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-1-03 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-1-04 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-2-01 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-2-02 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-2-03 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-2-04 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-3-01 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-3-02 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-3-03 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-3-04 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000MP-1-01 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000MP-1-02 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000MP-1-03 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000MP-1-04 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000MP-2-01 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000MP-2-02 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000MP-2-03 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000MP-2-04 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000MP-3-01 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000MP-3-02 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000MP-3-03 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000MP-3-04 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000RC-1-01 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000RC-1-02 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000RC-1-03 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000RC-1-04 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000RC-2-01 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000RC-2-02 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000RC-2-03 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000RC-2-04 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000RC-3-01 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000RC-3-02 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000RC-3-03 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | CS00000RC-3-04 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041739 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041740 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041742 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041743 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041744 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041746 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041748 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041749 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041752 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041753 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041754 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041756 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041757 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041759 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041760 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041761 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041770 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041771 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041773 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041775 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041776 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041777 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041778 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041780 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041784 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041786 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041787 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041788 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041789 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041792 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041793 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041795 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041797 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041800 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041801 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041802 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041804 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041805 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041806 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041808 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041810 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041813 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041815 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041816 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041817 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041820 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041830 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041831 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041833 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041838 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041840 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041841 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041842 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041843 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041845 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041846 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041847 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041850 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041852 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041854 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041859 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041861 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041869 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041870 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041872 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041873 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041875 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041876 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041879 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041880 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041884 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041886 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041888 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041890 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041891 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041892 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041893 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041894 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041895 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041902 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041903 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041906 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041909 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041913 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041915 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041918 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041919 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041738 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041741 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041745 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041747 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041750 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041751 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041755 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041758 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041762 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041763 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041764 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041765 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041766 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041767 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041768 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041769 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041772 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041774 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041779 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041781 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041782 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041783 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041785 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041790 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041791 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041794 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041796 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041798 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041799 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041803 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041807 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041809 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041811 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041812 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041814 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041818 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041819 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041821 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041822 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041823 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041824 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041825 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041826 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041827 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041828 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041829 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041832 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041834 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041835 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041836 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041837 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041839 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041844 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041848 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041849 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041851 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041853 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041855 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041856 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041857 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041858 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041860 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041862 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041863 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041864 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041865 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041866 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041867 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041868 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041871 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041874 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041877 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041878 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041881 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041882 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041883 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041885 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041887 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041889 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041896 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041897 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041898 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041899 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041900 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041901 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041904 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041905 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041907 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041908 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041910 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041911 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041912 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041914 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041916 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041917 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041920 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041921 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase POSITIVE (Named metabolites) | S00041922 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-01 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-02 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-03 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-04 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-05 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-06 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-07 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-08 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-09 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-10 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-11 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-01 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-02 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-03 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-04 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-05 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-06 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-07 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-08 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-09 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-10 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-11 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-12 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-01 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-02 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-03 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-04 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-05 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-06 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-07 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-08 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-09 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-10 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-11 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-12 | Sample type:batch pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-1-01 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-1-02 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-1-03 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-1-04 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-2-01 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-2-02 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-2-03 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-2-04 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-3-01 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-3-02 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-3-03 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-3-04 | Sample type:chear plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-1-01 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-1-02 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-1-03 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-1-04 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-2-01 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-2-02 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-2-03 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-2-04 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-3-01 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-3-02 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-3-03 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-3-04 | Sample type:master pool | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-1-01 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-1-02 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-1-03 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-1-04 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-2-01 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-2-02 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-2-03 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-2-04 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-3-01 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-3-02 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-3-03 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-3-04 | Sample type:red cross plasma | Gender:- | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041739 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041740 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041742 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041743 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041744 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041746 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041748 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041749 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041752 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041753 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041754 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041756 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041757 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041759 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041760 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041761 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041770 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041771 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041773 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041775 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041776 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041777 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041778 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041780 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041784 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041786 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041787 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041788 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041789 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041792 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041793 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041795 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041797 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041800 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041801 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041802 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041804 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041805 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041806 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041808 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041810 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041813 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041815 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041816 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041817 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041820 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041830 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041831 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041833 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041838 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041840 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041841 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041842 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041843 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041845 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041846 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041847 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041850 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041852 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041854 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041859 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041861 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041869 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041870 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041872 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041873 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041875 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041876 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041879 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041880 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041884 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041886 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041888 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041890 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041891 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041892 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041893 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041894 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041895 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041902 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041903 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041906 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041909 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041913 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041915 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041918 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041919 | Sample type:Sample | Gender:female | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041738 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041741 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041745 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041747 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041750 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041751 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041755 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041758 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041762 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041763 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041764 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041765 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041766 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041767 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041768 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041769 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041772 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041774 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041779 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041781 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041782 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041783 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041785 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041790 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041791 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041794 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041796 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041798 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041799 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041803 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041807 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041809 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041811 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041812 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041814 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041818 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041819 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041821 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041822 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041823 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041824 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041825 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041826 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041827 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041828 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041829 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041832 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041834 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041835 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041836 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041837 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041839 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041844 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041848 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041849 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041851 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041853 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041855 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041856 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041857 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041858 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041860 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041862 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041863 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041864 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041865 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041866 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041867 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041868 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041871 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041874 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041877 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041878 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041881 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041882 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041883 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041885 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041887 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041889 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041896 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041897 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041898 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041899 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041900 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041901 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041904 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041905 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041907 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041908 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041910 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041911 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041912 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041914 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041916 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041917 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041920 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041921 | Sample type:Sample | Gender:male | Peak area normalized |
Reversed Phase NEGATIVE (Named metabolites) | S00041922 | Sample type:Sample | Gender:male | Peak area normalized |